Please login to the form below

Not currently logged in
Email:
Password:

referendum

This page shows the latest referendum news and features for those working in and with pharma, biotech and healthcare.

Novo Nordisk invests £115m in Oxford diabetes unit

Novo Nordisk invests £115m in Oxford diabetes unit

AstraZeneca (AZ) is in the midst of setting up a new headquarters and R&D campus in Cambridge, although that project began ahead of the referendum. ... Speaking to the BBC, Novo's chief science officer Mads Thomsen said the EU referendum result had given

Latest news

  • Brexit - a tough pill to swallow Brexit - a tough pill to swallow

    All top ten global pharmaceutical companies operate in the UK. Immediately after the EU referendum result, the value of the pharmaceutical industry increased.

  • Surviving Brexit Surviving Brexit

    It may come as no surprise that a pre-referendum 'Brexit' poll conducted by the UK Pharmaceutical directors Club of senior management within the uK pharmaceutical industry resulted in a vast ... UK Government, industry and other EU and international

  • EMA: ‘business as usual’ - for now - after Brexit EMA: ‘business as usual’ - for now - after Brexit

    EMA would like to underline that its procedures and work streams are not affected by the outcome of the referendum,” it said. “ ... environment generated by the outcome of the UK referendum,” it said in a statement.

  • UK pharma faces 'immediate challenges' following Brexit UK pharma faces 'immediate challenges' following Brexit

    Nevertheless, the referendum's outcome caused shares to plunge and the pound hit a 31-year low as the markets reacted.

  • UK biotech beats fundraising records in 2015, says BIA UK biotech beats fundraising records in 2015, says BIA

    Despite the many positives, the BIA sounds a note of caution as issues such as uncertainty caused by the Brexit referendum later this month and reports of a lack of seed

More from news
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest Intelligence

  • Brexit Means Brexit Brexit Means Brexit

    Brexit Means Brexit. The differential destinations of post-Brexit pharma. “Brexit means Brexit.”The three little words that launched Theresa May’s leadership campaign in the aftermath of the EU referendum

  • Brexit implications for UK pharma legislation Brexit implications for UK pharma legislation

    Switzerland only regained full association to Horizon 2020 this year after not implementing EU migrant quotas voted for in a 2014 referendum.

  • Brexit: the facts (and the alternative facts) Brexit: the facts (and the alternative facts)

    Since the ‘Brexit’referendum last June, there has been much confusion and heated debate about what this actually means. ... As Teresa May said, before Brexit and her premiership, “It’s hard to think of an industry of greater strategic importance

  • Brexit: Implications for the pharma industry Brexit: Implications for the pharma industry

    Important points. The referendum is the first step; it’s unlikely there will be any significant change in the UK’s status in the EU prior to the UK leaving the

  • A rare talent A rare talent

    Europe. Now, with Brexit a reality, he says the referendum result hasn't caused Shire to put any of its plans on hold or stopped any investment in the UK. “

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 8 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Brandcast Health

Brandcast Health is a digital MedComms and patient-engagement agency who help our clients create and share engaging content. Our innovative...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics